SCHEMBL15883267

SCHEMBL15883267

COc1cc(OC)c(Cl)c(OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.53
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ KDM4E B2RXH2 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ CYP1A2 P05177 7/20 0.45
▸ CYP3A4 P08684 5/20 0.45
▸ CYP1A1 P04798 6/20 0.43
▸ CYP1B1 Q16678 6/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133298 0.85 ALDH1A1 (0.45) ALDH1A1CA12CA1CA2CA7
SCHEMBL1042771 0.84 TAAR1 (0.44) ALDH1A1CA12CA1CA2CA7
SCHEMBL1911832 0.84 ALDH1A1 (0.50) ALDH1A1CA12CA1CA2CA7
SCHEMBL16009653 0.84 ALDH1A1 (0.44) ALDH1A1CA12CA1CA2CA7
SCHEMBL10885926 0.84 CYP3A4 (0.53) ALDH1A1CA12CA1CA2CA7
SCHEMBL15180065 0.80 CA1 (0.53) ALDH1A1CA12CA1CA2CA7
SCHEMBL16133969 0.80 CYP2D6 (0.41) ALDH1A1CA12CA1CA2CA7
SCHEMBL10044442 0.80 CYP1A2 (0.44) ALDH1A1CA12CA1CA2CA7
SCHEMBL736513 0.79 ALDH1A1 (0.56) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL15127717 0.79 NPC1 (0.38) ALDH1A1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120097814-A Method for carrying out photocatalytic chlorination reaction by utilizing carbon nitride microspheres in microchannel reactor 福州大学 2025-06-06 — — CN disclosed
US-11572348-B2 Syntheses of N-heterocyclic carbenes and intermediates therefor UMICORE AG & CO. KG (DE) 2023-02-07 — — US disclosed
US-11572348-B2 Syntheses of N-heterocyclic carbenes and intermediates therefor UMICORE AG & CO. KG (DE) 2023-02-07 — — US disclosed
US-20210317088-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2021-10-14 — — US disclosed
US-20210317088-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2021-10-14 — — US disclosed
US-20200354323-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2020-11-12 — — US disclosed
US-20200354323-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2020-11-12 — — US disclosed
US-10759763-B2 Syntheses of N-heterocyclic carbenes and intermediates therefor UMICORE AG & CO. KG (DE) 2020-09-01 — — US disclosed
US-10759763-B2 Syntheses of N-heterocyclic carbenes and intermediates therefor UMICORE AG & CO. KG (DE) 2020-09-01 — — US disclosed
EP-2943471-B1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO KG (DE) 2020-03-11 — — EP disclosed
US-9890125-B2 Syntheses of N-heterocyclic carbenes and intermediates therefor UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) 2018-02-13 — — US disclosed
CN-104981460-B Synthesis of N-heterocyclic carbenes and intermediates thereof 圣安德鲁斯大学董事会 2018-01-23 — — CN disclosed
US-20170152231-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2017-06-01 — — US disclosed
US-20170152231-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2017-06-01 — — US disclosed
US-20170152231-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2017-06-01 — — US disclosed
US-20150361049-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UNIV ST ANDREWS (GB) 2015-12-17 — — US disclosed
US-20150361049-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UNIV ST ANDREWS (GB) 2015-12-17 — — US disclosed
US-20150361049-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UNIV ST ANDREWS (GB) 2015-12-17 — — US disclosed
CN-104649854-A Cheap and efficient preparation method of aryl halides UNIV BEIJING 2015-05-27 — — CN disclosed
WO-2014108671-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) 2014-07-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10759763-B2 Syntheses of N-heterocyclic carbenes and intermediates therefor GRHPR, DDC, NDC1 ALDH1A1 726/4885CA12 538/4885CA1 508/4885
US-11572348-B2 Syntheses of N-heterocyclic carbenes and intermediates therefor GRHPR, DDC, NDC1 ALDH1A1 726/4885CA12 538/4885CA1 508/4885
US-20170152231-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR GRHPR, DDC, WEE2 ALDH1A1 748/4885CA12 597/4885CA1 531/4885
US-20210317088-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR GRHPR, DDC, NDC1 ALDH1A1 726/4885CA12 538/4885CA1 508/4885
US-20200354323-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR GRHPR, DDC, NDC1 ALDH1A1 726/4885CA12 538/4885CA1 508/4885
US-20150361049-A1 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR GRHPR, DDC, WEE2 ALDH1A1 748/4885CA12 597/4885CA1 531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback